Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation

Toxicology in Vitro

Volumn 29, Issue 1, 2015, Pages 195-203

  Aldossari, Abdullah A ^a   Shannahan, Jonathan H ^a   Podila, Ramakrishna ^b   Brown, Jared M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Bone marrow derived mast cell; Lamp2; Osteopontin; Scavenger receptor B1; Silver nanoparticles

Indexed keywords

OSTEOPONTIN; SCAVENGER RECEPTOR BI; SILVER NANOPARTICLE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; METAL NANOPARTICLE; SILVER;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL INTERACTION; CHEMICAL INTERACTION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; IMMUNE RESPONSE; MAST CELL; MAST CELL DEGRANULATION; MATERIAL COATING; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SURFACE PROPERTY; SUSPENSION; ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; BIOSYNTHESIS; C57BL MOUSE; CELLULAR IMMUNITY; DEGRANULATION; DRUG EFFECTS;

ANIMALS; CELL DEGRANULATION; IMMUNITY, CELLULAR; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MAST CELLS; METAL NANOPARTICLES; MICE, INBRED C57BL; OSTEOPONTIN; SILVER; SPECTROPHOTOMETRY, ATOMIC;

EID: 84910122442     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.10.008     Document Type: Article

References (58)

1. Baranova I.N., Vishnyakova T.G., Bocharov A.V., Kurlander R., Chen Z., Kimelman M.L., Remaley A.T., Csako G., Thomas F., Eggerman T.L., Patterson A.P. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2005, 280:8031-8040.
2. Berezin A.E., Kremzer A.A. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis 2013, 229:475-481.
3. Brown J.M., Swindle E.J., Kushnir-Sukhov N.M., Holian A., Metcalfe D.D. Silica-directed mast cell activation is enhanced by scavenger receptors. Am. J. Respir. Cell Mol. Biol. 2007, 36:43-52.
4. Brown J.M., Wilson T.M., Metcalfe D.D. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 2008, 38:4-18.
5. Canton J., Neculai D., Grinstein S. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 2013, 13:621-634.
6. Carlson C., Hussain S.M., Schrand A.M.K., Braydich-Stolle L., Hess K.L., Jones R.L., Schlager J.J. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112:13608-13619.
7. Catanese M.T., Loureiro J., Jones C.T., Dorner M., von Hahn T., Rice C.M. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission. J. Virol. 2013, 87:8282-8293.
8. Champion J.A., Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4930-4934.
9. Champion J.A., Katare Y.K., Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release 2007, 121:3-9.
10. Christensen F.M., Johnston H.J., Stone V., Aitken R.J., Hankin S., Peters S., Aschberger K. Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2010, 4:284-295.
11. Dellinger A., Zhou Z., Norton S.K., Lenk R., Conrad D., Kepley C.L. Uptake and distribution of fullerenes in human mast cells. Nanomedicine 2010, 6:575-582.
12. Dong C., Yan Z., Kokx J., Chrisey D.B., Dinu C.Z. Antibacterial and surface-enhanced Raman scattering (SERS) activities of AgCl cubes synthesized by pulsed laser ablation in liquid. Appl. Surf. Sci. 2012, 258:9218-9222.
13. Echegoyen Y., Nerín C. Nanoparticle release from nano-silver antimicrobial food containers. Food Chem. Toxicol. 2013, 62:16-22.
14. Eyre N.S., Drummer H.E., Beard M.R. The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog. 2010, 6:e1001130.
15. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:333-337.
16. Hamilton R.F., Wu Z., Mitra S., Shaw P.K., Holian A. Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol. 2013, 10:57.
17. Harris B.J., Dalhaimer P. Particle shape effects in vitro and in vivo. Front. Biosci. (Schol Ed) 2012, 4:1344-1353.
18. Huang Y.F., Liu H., Xiong X., Chen Y., Tan W. Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells. J. Am. Chem. Soc. 2009, 131:17328-17334.
19. Iwaki S., Tkaczyk C., Satterthwaite A.B., Halcomb K., Beaven M.A., Metcalfe D.D., Gilfillan A.M. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit. J. Biol. Chem. 2005, 280:40261-40270.
20. Katwa P., Wang X., Urankar R.N., Podila R., Hilderbrand S.C., Fick R.B., Rao A.M., Ke P.C., Wingard C.J., Brown J.M. A carbon nanotube toxicity paradigm driven by mast cells and the IL-(3)(3)/ST(2) axis. Small 2012, 8:2904-2912.
21. Kittler S., Greulich C., Diendorf J., Köller M., Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 2010, 22:4548-4554.
22. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 1994, 63:601-637.
23. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 1996, 98:984-995.
24. Levard C., Mitra S., Yang T., Jew A.D., Badireddy A.R., Lowry G.V., Brown G.E. Effect of chloride on the dissolution rate of silver nanoparticles and toxicity to E. coli. Environ. Sci. Technol. 2013, 47:5738-5745.
25. Li R., Wang X., Ji Z., Sun B., Zhang H., Chang C.H., Lin S., Meng H., Liao Y.P., Wang M., Li Z., Hwang A.A., Song T.B., Xu R., Yang Y., Zink J.I., Nel A.E., Xia T. Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano 2013, 7:2352-2368.
26. Marquis B.J., Maurer-Jones M.A., Braun K.L., Haynes C.L. Amperometric assessment of functional changes in nanoparticle-exposed immune cells: varying Au nanoparticle exposure time and concentration. Analyst 2009, 134:2293-2300.
27. Marquis B.J., Liu Z., Braun K.L., Haynes C.L. Investigation of noble metal nanoparticle [small zeta]-potential effects on single-cell exocytosis function in vitro with carbon-fiber microelectrode amperometry. Analyst 2011, 136:3478-3486.
28. Maurer-Jones M.A., Lin Y.S., Haynes C.L. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 2010, 4:3363-3373.
29. McCurdy J.D., Olynych T.J., Maher L.H., Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 2003, 170:1625-1629.
30. Medic N., Vita F., Abbate R., Soranzo M.R., Pacor S., Fabbretti E., Borelli V., Zabucchi G. Mast cell activation by myelin through scavenger receptor. J. Neuroimmunol. 2008, 200:27-40.
31. Miethling-Graff R., Rumpker R., Richter M., Verano-Braga T., Kjeldsen F., Brewer J., Hoyland J., Rubahn H.G., Erdmann H. Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol. In Vitro 2014, 28:1280-1289.
32. Mooberry L.K., Nair M., Paranjape S., McConathy W.J., Lacko A.G. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J. Drug Target. 2010, 18:53-58.
33. Murao K., Terpstra V., Green S.R., Kondratenko N., Steinberg D., Quehenberger O. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 1997, 272:17551-17557.
34. Nishanth R.P., Jyotsna R.G., Schlager J.J., Hussain S.M., Reddanna P. Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: Role of ROS-NFκB signaling pathway. Nanotoxicology 2011, 5:502-516.
35. Nocchetti M., Donnadio A., Ambrogi V., Andreani P., Bastianini M., Pietrella D., Latterini L. Ag/AgCl nanoparticle decorated layered double hydroxides: synthesis, characterization and antimicrobial properties. J. Mater. Chem. B 2013, 1:2383-2393.
36. Pass H.I., Carbone M. Current status of screening for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg. 2009, 21:97-104.
37. Piccinno F., Gottschalk F., Seeger S., Nowack B. Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world. J. Nanopart. Res. 2012, 14:1-11.
38. Podila R., Brown J.M. Toxicity of engineered nanomaterials: a physicochemical perspective. J. Biochem. Mol. Toxicol. 2013, 27:50-55.
39. Podila R., Chen R., Ke P.C., Brown J.M., Rao A.M. Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl. Phys. Lett. 2012, 101:263701.
40. Project, 2014. Project on Emerging Nanotechnologies. Consumer Products Inventory. (retrieved 2014). http://www.nanotechproject.org/cpi.
41. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., Murdock R.C., Schlager J.J., Hussain S.M., Ali S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 2009, 187:15-21.
42. Rigotti A., Trigatti B., Babitt J., Penman M., Xu S., Krieger M. Scavenger receptor BI-a cell surface receptor for high density lipoprotein. Curr. Opin. Lipidol. 1997, 8:181-188.
43. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:12610-12615.
44. Ryan J.J., Bateman H.R., Stover A., Gomez G., Norton S.K., Zhao W., Schwartz L.B., Lenk R., Kepley C.L. Fullerene nanomaterials inhibit the allergic response. J. Immunol. 2007, 179:665-672.
45. Shannahan J.H., Brown J.M. Engineered nanomaterial exposure and the risk of allergic disease. Curr. Opin. Allergy Clin. Immunol. 2014, 14:95-99.
46. Shannahan J.H., Kodavanti U.P., Brown J.M. Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal. Toxicol. 2012, 24:320-339.
47. Sharma G., Valenta D.T., Altman Y., Harvey S., Xie H., Mitragotri S., Smith J.W. Polymer particle shape independently influences binding and internalization by macrophages. J. Control. Release 2010, 147:408-412.
48. Singh R.P., Ramarao P. Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol. Lett. 2012, 213:249-259.
49. Sung J.H., Ji J.H., Yoon J.U., Kim D.S., Song M.Y., Jeong J., Han B.S., Han J.H., Chung Y.H., Kim J., Kim T.S., Chang H.K., Lee E.J., Lee J.H., Yu I.J. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhalation Toxicol. 2008, 20:567-574.
50. Sunshine J.C., Perica K., Schneck J.P., Green J.J. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials 2014, 35:269-277.
51. Tang J., Xiong L., Wang S., Wang J., Liu L., Li J., Yuan F., Xi T. Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol. 2009, 9:4924-4932.
52. Tiwari D.K., Jin T., Behari J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol. Mech. Methods 2011, 21:13-24.
53. Umemoto E.Y., Speck M., Shimoda L.M., Kahue K., Sung C., Stokes A.J., Turner H. Single-walled carbon nanotube exposure induces membrane rearrangement and suppression of receptor-mediated signalling pathways in model mast cells. Toxicol. Lett. 2014, 229:198-209.
54. Wingard C.J., Walters D.M., Cathey B.L., Hilderbrand S.C., Katwa P., Lin S., Ke P.C., Podila R., Rao A., Lust R.M., Brown J.M. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 2011, 5:531-545.
55. Xia T., Hamilton R.F., Bonner J.C., Crandall E.D., Elder A., Fazlollahi F., Girtsman T.A., Kim K., Mitra S., Ntim S.A., Orr G., Tagmount M., Taylor A.J., Telesca D., Tolic A., Vulpe C.D., Walker A.J., Wang X., Witzmann F.A., Wu N., Xie Y., Zink J.I., Nel A., Holian A. Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ. Health Perspect. 2013, 121:683-690.
56. Yang G.H., Fan J., Xu Y., Qiu S.J., Yang X.R., Shi G.M., Wu B., Dai Z., Liu Y.K., Tang Z.Y., Zhou J. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist 2008, 13:1155-1165.
57. Yang W., Lee S., Lee J., Bae Y., Kim D. Silver nanoparticle-induced degranulation observed with quantitative phase microscopy. J. Biomed. Opt. 2010, 15:045005.
58. Zhu P., Liu X., Treml L.S., Cancro M.P., Freedman B.D. Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells. J. Biol. Chem. 2009, 284:22878-22887.